Résultats de la recherche - 23 results
Emergence of ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.
Most frequent were (n = 230) and (n = 224), detected in 14 and 12 countries, respectively. Isolates carrying have increased rapidly since 2021. The increasing detection of carbapenemase genes in the ...
Antimicrobial resistance in ESBL and indicator E. coli, Campylobacter spp.,Salmonella spp., methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis and faecium isolated from food and food-producing animals (primary production) in 2023
included ciprofloxacin combined with tetracycline. However, resistance to tetracycline was lower in 2023 (42.9%) than in 2022 (54.3%). Resistance to ertapenem in C. jejuni increased in 2022 (13.0%) and again ...
Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
mph(A) operon structures in susceptible and resistant isolates increases the predictive power of WGS-based methods for in silico detection of azithromycin resistance in Enterobacterales. Health Topics: ...
Animal sources of antimicrobial-resistant bacterial infections in humans: a systematic review
direct contribution of animal sources of AMR are rare but increasing. More recent publications tailor their methodologies increasingly towards the AMR hazard as a whole, providing grounds for future ...
Antimicrobial resistance in ESBL and indicator E.coli, Campylobacter spp., Salmonella spp., methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus faecalis and faecium isolated from food and food-producing animals (primary production) in 2022
included ciprofloxacin combined with tetracycline. An increase in resistance to these antibiotics as well as to ertapenem and erythromycin was seen in 2022. Multidrug resistance in C. jejuni also increased ...
Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case–control study
Abstract: Objectives To investigate whether prior exposure to non-fluoroquinolone antibiotics increases the risk of fluoroquinolone resistance in Escherichia coli. Methods This was a secondary analysis of ...
Superficial mycoses in Belgium: Burden, costs and antifungal drugs consumption
mainly from packaging changes and increased self‐medication. A significant decrease in itraconazole treatments was notably compensated by an increased prescription of fluconazole packages. Conclusion This ...
Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients
in 2005 and 2011-12, respectively, with most patients being women (79% in both study periods). The prevalence of MDR increased from 28.4% (2758/9704) in 2005 to 34.3% (4286/12512) in 2011-12 (adjusted ...
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
deaths and 874 541 (768 837-989 068) DALY s. The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy ...
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016
Enterobacteriaceae, especially in Klebsiella pneumoniae (K. pneumoniae) in acute care hospitals. The mean resistance proportion of extended beta-lactamase producing (ESBL +) K. pneumoniae increased from 6.2% in 2005 to ...